Informations:
Erreur:
ID
19901
Description
The purpose of this study is to determine the safety and efficacy of natalizumab in the treatment of individuals who have been diagnosed with relapsing remitting multiple sclerosis (MS). It is hoped that natalizumab will prevent certain types of white blood cells from moving out of the bloodstream into organs, including the brain, that are being damaged by autoimmune disease (a disease in which the body's own immune system attacks certain organs). These white blood cells are thought to cause inflammation that can result in lesions (small areas of damage) in the brain. These lesions are thought to be the cause of relapses and disability in MS.
Mots-clés
Versions (1)
- 30/01/2017 30/01/2017 -
Téléchargé le
30 janvier 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Concomitant Medication CRFs Multiple Sclerosis Tysabri NCT00027300
Concomitant Medication CRFs Multiple Sclerosis Tysabri NCT00027300
Similar models
Concomitant Medication CRFs Multiple Sclerosis Tysabri NCT00027300
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
medication name
Item
1. Medication Name
text
C2360065 (UMLS CUI [1])
dose/ units
Item
1. Dose/ Units
text
C3174092 (UMLS CUI [1])
frequency
Item
1. Frequency
text
C3476109 (UMLS CUI [1])
route
Item
1. Route
text
C0013153 (UMLS CUI [1])
indication
Item
1. Indication
text
C3146298 (UMLS CUI [1])
start date
Item
1. Start Date
date
C0808070 (UMLS CUI [1])
stop date
Item
1. Stop Date
date
C0806020 (UMLS CUI [1])
medication name
Item
2. Medication Name
text
C2360065 (UMLS CUI [1])
dose/ units
Item
2. Dose/ Units
text
C3174092 (UMLS CUI [1])
frequency
Item
2. Frequency
text
C3476109 (UMLS CUI [1])
route
Item
2. Route
text
C0013153 (UMLS CUI [1])
indication
Item
2. Indication
text
C3146298 (UMLS CUI [1])
start date
Item
2. Start Date
date
C0808070 (UMLS CUI [1])
stop date
Item
2. Stop Date
date
C0806020 (UMLS CUI [1])
medication name
Item
3. Medication Name
text
C2360065 (UMLS CUI [1])
dose/ units
Item
3. Dose/ Units
text
C3174092 (UMLS CUI [1])
frequency
Item
3. Frequency
text
C3476109 (UMLS CUI [1])
route
Item
3. Route
text
C0013153 (UMLS CUI [1])
indication
Item
3. Indication
text
C3146298 (UMLS CUI [1])
start date
Item
3. Start Date
date
C0808070 (UMLS CUI [1])
stop date
Item
3. Stop Date
date
C0806020 (UMLS CUI [1])
medication name
Item
4. Medication Name
text
C2360065 (UMLS CUI [1])
dose/ units
Item
4. Dose/ Units
text
C3174092 (UMLS CUI [1])
frequency
Item
4. Frequency
text
C3476109 (UMLS CUI [1])
route
Item
4. Route
text
C0013153 (UMLS CUI [1])
indication
Item
4. Indication
text
C3146298 (UMLS CUI [1])
start date
Item
4. Start Date
date
C0808070 (UMLS CUI [1])
stop date
Item
4. Stop Date
date
C0806020 (UMLS CUI [1])
medication name
Item
5. Medication Name
text
C2360065 (UMLS CUI [1])
dose/ units
Item
5. Dose/ Units
text
C3174092 (UMLS CUI [1])
frequency
Item
5. Frequency
text
C3476109 (UMLS CUI [1])
route
Item
5. Route
text
C0013153 (UMLS CUI [1])
indication
Item
5. Indication
text
C3146298 (UMLS CUI [1])
start date
Item
5. Start Date
date
C0808070 (UMLS CUI [1])
stop date
Item
5. Stop Date
date
C0806020 (UMLS CUI [1])
medication name
Item
6. Medication Name
text
C2360065 (UMLS CUI [1])
dose/ units
Item
6. Dose/ Units
text
C3174092 (UMLS CUI [1])
frequency
Item
6. Frequency
text
C3476109 (UMLS CUI [1])
route
Item
6. Route
text
C0013153 (UMLS CUI [1])
indication
Item
6. Indication
text
C3146298 (UMLS CUI [1])
start date
Item
6. Start Date
date
C0808070 (UMLS CUI [1])
stop date
Item
6. Stop Date
date
C0806020 (UMLS CUI [1])
medication name
Item
7. Medication Name
text
C2360065 (UMLS CUI [1])
dose/ units
Item
7. Dose/ Units
text
C3174092 (UMLS CUI [1])
frequency
Item
7. Frequency
text
C3476109 (UMLS CUI [1])
route
Item
7. Route
text
C0013153 (UMLS CUI [1])
indication
Item
7. Indication
text
C3146298 (UMLS CUI [1])
start date
Item
7. Start Date
date
C0808070 (UMLS CUI [1])
stop date
Item
7. Stop Date
date
C0806020 (UMLS CUI [1])
medication name
Item
8. Medication Name
text
C2360065 (UMLS CUI [1])
dose/ units
Item
8. Dose/ Units
text
C3174092 (UMLS CUI [1])
frequency
Item
8. Frequency
text
C3476109 (UMLS CUI [1])
route
Item
8. Route
text
C0013153 (UMLS CUI [1])
indication
Item
8. Indication
text
C3146298 (UMLS CUI [1])
start date
Item
8. Start Date
date
C0808070 (UMLS CUI [1])
stop date
Item
8. Stop Date
date
C0806020 (UMLS CUI [1])
medication name
Item
9. Medication Name
text
C2360065 (UMLS CUI [1])
dose/ units
Item
9. Dose/ Units
text
C3174092 (UMLS CUI [1])
frequency
Item
9. Frequency
text
C3476109 (UMLS CUI [1])
route
Item
9. Route
text
C0013153 (UMLS CUI [1])
indication
Item
9. Indication
text
C3146298 (UMLS CUI [1])
start date
Item
9. Start Date
date
C0808070 (UMLS CUI [1])
stop date
Item
9. Stop Date
date
C0806020 (UMLS CUI [1])
medication name
Item
10. Medication Name
text
C2360065 (UMLS CUI [1])
dose/ units
Item
10. Dose/ Units
text
C3174092 (UMLS CUI [1])
frequency
Item
10. Frequency
text
C3476109 (UMLS CUI [1])
route
Item
10. Route
text
C0013153 (UMLS CUI [1])
indication
Item
10. Indication
text
C3146298 (UMLS CUI [1])
start date
Item
10. Start Date
date
C0808070 (UMLS CUI [1])
stop date
Item
10. Stop Date
date
C0806020 (UMLS CUI [1])